Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on March 14, 2023. The filing serves to distribute a press release dated March 14, 2023, to U.S. investors. The registrant files annual reports under Form 20-F.
Financial Metrics
The provided filing text contains only the cover page and exhibit index. It does not include the content of the press release or any financial statements. Consequently, there is no data available regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. The nature of the update is limited to the distribution of a press release, the content of which is not included in the source text.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided text. The document solely references the existence of a press release as Exhibit 99.1.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K referencing a press release dated March 14, 2023.
- The actual content of the press release (Exhibit 99.1) is not included in the provided text.
- Investors must locate the full press release to obtain details on the company's operational or financial status.
- The Chief Executive Officer, André Choulika, signed the report on behalf of the registrant.